Cambridge, United Kingdom

Susan Marie Metcalfe

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Yale University, Other. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Marie Metcalfe. Retrieved from https://idiyas.com/inventor/susan-marie-metcalfe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susan Marie Metcalfe: Innovator in Neurotherapeutics

Introduction

Susan Marie Metcalfe is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of neurotherapeutics, holding 2 patents that focus on innovative treatments for neurodegenerative diseases and immune modulation.

Latest Patents

Her latest patents include "Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor." This invention provides compositions and methods for treating neurodegenerative diseases and central nervous system injuries. The compositions consist of a pharmaceutically acceptable carrier solution and a plurality of biodegradable nanoparticles. These nanoparticles are designed to selectively bind to the surface of neural stem cells and incorporate factors such as leukemia inhibitory factor (LIF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF). The biodegradable nanoparticles are capable of delivering these factors via controlled time release. Another notable patent is the "Immuno-modulatory composition," which modulates the immune response in mammals. This composition also utilizes biodegradable nanoparticles that selectively bind to T lymphocyte cells and vascular endothelial cells, incorporating leukemia inhibitory factor (LIF) to guide tolerogenesis in patients.

Career Highlights

Throughout her career, Susan has worked with prestigious institutions, including Yale University. Her research has focused on developing innovative solutions for complex medical challenges, particularly in the realm of neurotherapeutics.

Collaborations

One of her notable collaborators is Tarek M Fahmy, with whom she has worked on advancing her research and patent applications.

Conclusion

Susan Marie Metcalfe's contributions to neurotherapeutics and immune modulation highlight her role as a leading inventor in her field. Her innovative patents reflect her commitment to improving treatment options for patients with neurodegenerative diseases and autoimmune conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…